Biodexa Pharmaceuticals

NASDAQ: BDRX · Real-Time Price · USD
7.01
-0.03 (-0.43%)
At close: Aug 15, 2025, 2:59 PM

Biodexa Pharmaceuticals Cash Flow Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-5.73M -7.08M -7.66M -5.46M
Depreciation & Amortization
254K 283K 343K 403K
Stock-Based Compensation
283K 28K 123K 89K
Other Working Capital
2.24M -414K 513K -130K
Other Non-Cash Items
-3.08M 397K 454K -892K
Deferred Income Tax
-250K -406K -832K 469K
Change in Working Capital
-3.74M -49K 520K -617K
Operating Cash Flow
-12.26M -6.83M -7.05M -6.01M
Capital Expenditures
-774K -263K -62K -320K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-589K -239K -158K 42K
Investing Cash Flow
-598K -265K -220K -278K
Debt Repayment
245K -188K -178K -215K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -13K -18K -15K
Financial Cash Flow
8.56M 10.23M 47K 8.8M
Net Cash Flow
-4.3M 3.13M -7.22M 2.51M
Free Cash Flow
-13.04M -7.09M -7.11M -6.33M